For the Epi_C1 clusters, we further classified cells into CD44-positive and CD44-negative clusters based on CD44 expression, referring to them as CD44+ and CD44- Epi_C1, respectively, to explore the specific functions of CD44+ tumor cells at the leading edge of CRC tissues. The gene discussed is CD44; the disease is colorectal carcinoma.